Treatment of Postherpetic Pain With Scrambler Therapy, a Patient-Specific Neurocutaneous Electrical Stimulation Device

Thomas J Smith, Giuseppe Marineo

Research output: Contribution to journalArticle

Abstract

Objectives: Postherpetic neuropathy (PHN) is common, severe, and often refractory to treatment. We treated 10 patients with refractory PHN using Scrambler therapy, a neurocutaneous stimulation device that delivers “nonpain” information with surface electrodes. Methods: Scrambler therapy was given as 30-minute sessions daily for 10 days. Pain was recorded before and after treatment. Two centers. Result: The average pain score rapidly diminished from 7.64 ± 1.46 at baseline to 0.42 ± 0.89 at 1 month, a 95% reduction, with continued relief at 2 and 3 months. Patients achieved maximum pain relief with less than 5 treatments. Discussion: Scrambler therapy appears to have a promising effect on PHN, with prompt and continued relief and no side effects. Further research is warranted.

Original languageEnglish (US)
Pages (from-to)812-813
Number of pages2
JournalAmerican Journal of Hospice and Palliative Medicine
Volume35
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Electric Stimulation
Pain
Equipment and Supplies
Therapeutics
Electrodes
Research

Keywords

  • devices
  • electrical pain stimulation
  • neurocutaneous pain stimulation
  • new therapies for pain
  • pain
  • postherpetic neuropathy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{924c33368fbd49779733714483147bcd,
title = "Treatment of Postherpetic Pain With Scrambler Therapy, a Patient-Specific Neurocutaneous Electrical Stimulation Device",
abstract = "Objectives: Postherpetic neuropathy (PHN) is common, severe, and often refractory to treatment. We treated 10 patients with refractory PHN using Scrambler therapy, a neurocutaneous stimulation device that delivers “nonpain” information with surface electrodes. Methods: Scrambler therapy was given as 30-minute sessions daily for 10 days. Pain was recorded before and after treatment. Two centers. Result: The average pain score rapidly diminished from 7.64 ± 1.46 at baseline to 0.42 ± 0.89 at 1 month, a 95{\%} reduction, with continued relief at 2 and 3 months. Patients achieved maximum pain relief with less than 5 treatments. Discussion: Scrambler therapy appears to have a promising effect on PHN, with prompt and continued relief and no side effects. Further research is warranted.",
keywords = "devices, electrical pain stimulation, neurocutaneous pain stimulation, new therapies for pain, pain, postherpetic neuropathy",
author = "Smith, {Thomas J} and Giuseppe Marineo",
year = "2018",
month = "5",
day = "1",
doi = "10.1177/1049909113494002",
language = "English (US)",
volume = "35",
pages = "812--813",
journal = "American Journal of Hospice and Palliative Medicine",
issn = "1049-9091",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Treatment of Postherpetic Pain With Scrambler Therapy, a Patient-Specific Neurocutaneous Electrical Stimulation Device

AU - Smith, Thomas J

AU - Marineo, Giuseppe

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Objectives: Postherpetic neuropathy (PHN) is common, severe, and often refractory to treatment. We treated 10 patients with refractory PHN using Scrambler therapy, a neurocutaneous stimulation device that delivers “nonpain” information with surface electrodes. Methods: Scrambler therapy was given as 30-minute sessions daily for 10 days. Pain was recorded before and after treatment. Two centers. Result: The average pain score rapidly diminished from 7.64 ± 1.46 at baseline to 0.42 ± 0.89 at 1 month, a 95% reduction, with continued relief at 2 and 3 months. Patients achieved maximum pain relief with less than 5 treatments. Discussion: Scrambler therapy appears to have a promising effect on PHN, with prompt and continued relief and no side effects. Further research is warranted.

AB - Objectives: Postherpetic neuropathy (PHN) is common, severe, and often refractory to treatment. We treated 10 patients with refractory PHN using Scrambler therapy, a neurocutaneous stimulation device that delivers “nonpain” information with surface electrodes. Methods: Scrambler therapy was given as 30-minute sessions daily for 10 days. Pain was recorded before and after treatment. Two centers. Result: The average pain score rapidly diminished from 7.64 ± 1.46 at baseline to 0.42 ± 0.89 at 1 month, a 95% reduction, with continued relief at 2 and 3 months. Patients achieved maximum pain relief with less than 5 treatments. Discussion: Scrambler therapy appears to have a promising effect on PHN, with prompt and continued relief and no side effects. Further research is warranted.

KW - devices

KW - electrical pain stimulation

KW - neurocutaneous pain stimulation

KW - new therapies for pain

KW - pain

KW - postherpetic neuropathy

UR - http://www.scopus.com/inward/record.url?scp=84921056354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921056354&partnerID=8YFLogxK

U2 - 10.1177/1049909113494002

DO - 10.1177/1049909113494002

M3 - Article

VL - 35

SP - 812

EP - 813

JO - American Journal of Hospice and Palliative Medicine

JF - American Journal of Hospice and Palliative Medicine

SN - 1049-9091

IS - 5

ER -